risperidone has been researched along with clopenthixol in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (9.09) | 18.2507 |
| 2000's | 15 (68.18) | 29.6817 |
| 2010's | 3 (13.64) | 24.3611 |
| 2020's | 2 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Huttunen, MO; Larmo, I; Nyholm, R; Piepponen, T; Raitasuo, V; Rantanen, H | 1 |
| Finkel, B; Lerner, A; Oyffe, I; Rudinski, D; Sigal, M; Weizman, A | 1 |
| Starr, JM | 1 |
| Glenthoj, BY; Kristiansen, KT; Mackeprang, T | 1 |
| Bilici, M; Cakirbay, H; Guler, M; Tan, U; Tosun, M; Ulgen, M | 1 |
| Bellgrove, MA; Bradshaw, JL; Vance, A | 1 |
| Drobizhev, MIu; Kozyrev, VN; Kraeva, GK; Kubrakov, MA; Smulevich, AB | 1 |
| Fagerlund, B; Gade, A; Glenthøj, BY; Mackeprang, T | 1 |
| Eerdekens, E; Eerdekens, M; Jacko, M; Turner, M | 1 |
| Bäumer, D; Ebert, D; Tebartz van Elst, L; Trimble, MR | 1 |
| Barna, I; Gazdag, G; Iványi, Z; Tolna, J | 1 |
| Dries, PJ; Hovens, JE; Loonen, AJ; Melman, CT; Wapenaar, RJ | 1 |
| Glick, ID; Schreiner, A; Shkedy, Z | 1 |
| Alamo, C; Jiménez-Arriero, MA; López-Muñoz, F; Martínez, I; Ponce, G; Rubio, G | 1 |
| Baaré, WF; Glenthoj, A; Glenthoj, BY; Hemmingsen, RP; Jernigan, TL; Mackeprang, T; Pagsberg, AK | 1 |
| Kumar, A; Strech, D | 1 |
| Aker, AT; Bos Gelmez, SÜ; Cerit, C; Ozten, E; Vural, M; Yıldız, M | 1 |
| Friis, S; Haahr, U; Johannessen, JO; Larsen, TK; McGlashan, TH; Melle, I; Opjordsmoen, S; Rund, BR; Simonsen, E; Vaglum, P | 1 |
| Pischinger, B; Rosenleitner, J; Yazdi, K | 1 |
| Allerup, PN; Ebdrup, BH; Fagerlund, B; Friberg, L; Glenthøj, BY; Nørbak-Emig, H; Pinborg, LH; Rasmussen, H; Rostrup, E; Svarer, C | 1 |
| Barbui, C; Bertolini, F; Bovo, C; Correll, CU; Del Giovane, C; Gastaldon, C; Nosé, M; Ogheri, F; Ostuzzi, G; Papola, D; Purgato, M; Tedeschi, F; Turrini, G | 1 |
| Osman, E; Yıldız, M | 1 |
2 review(s) available for risperidone and clopenthixol
| Article | Year |
|---|---|
Zuclopenthixol dihydrochloride for schizophrenia.
Topics: Antipsychotic Agents; Clopenthixol; Dyskinesia, Drug-Induced; Humans; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Schizophrenic Psychology; Sulpiride | 2009 |
Maintenance Treatment With Long-Acting Injectable Antipsychotics for People With Nonaffective Psychoses: A Network Meta-Analysis.
Topics: Antipsychotic Agents; Aripiprazole; Clopenthixol; Delayed-Action Preparations; Flupenthixol; Fluphenazine; Haloperidol; Humans; Injections, Intramuscular; Network Meta-Analysis; Olanzapine; Paliperidone Palmitate; Patient Acceptance of Health Care; Phenothiazines; Psychotic Disorders; Risperidone; Schizophrenia; Secondary Prevention | 2021 |
10 trial(s) available for risperidone and clopenthixol
| Article | Year |
|---|---|
Risperidone versus zuclopenthixol in the treatment of acute schizophrenic episodes: a double-blind parallel-group trial.
Topics: Acute Disease; Adolescent; Adult; Aged; Antipsychotic Agents; Clopenthixol; Double-Blind Method; Female; Humans; Isoxazoles; Male; Middle Aged; Piperidines; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Schizophrenic Psychology | 1995 |
Effects of antipsychotics on prepulse inhibition of the startle response in drug-naïve schizophrenic patients.
Topics: Adult; Antipsychotic Agents; Clopenthixol; Female; Follow-Up Studies; Habituation, Psychophysiologic; Humans; Longitudinal Studies; Male; Neural Inhibition; Reflex, Startle; Risperidone; Schizophrenia | 2002 |
Classical and atypical neuroleptics, and bone mineral density, in patients with schizophrenia.
Topics: Adult; Analysis of Variance; Antipsychotic Agents; Benzodiazepines; Bone Density; Clopenthixol; Clozapine; Female; Fluphenazine; Haloperidol; Humans; Male; Olanzapine; Pirenzepine; Risperidone; Schizophrenia | 2002 |
Effects of low-dose risperidone and low-dose zuclopenthixol on cognitive functions in first-episode drug-naive schizophrenic patients.
Topics: Adult; Antipsychotic Agents; Clopenthixol; Cognition; Dose-Response Relationship, Drug; Female; Humans; Male; Risperidone; Schizophrenia | 2004 |
Long-acting injectable risperidone: safety and efficacy in stable patients switched from conventional depot antipsychotics.
Topics: Adult; Antipsychotic Agents; Clopenthixol; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Flupenthixol; Fluphenazine; Haloperidol; Humans; Injections, Intramuscular; Male; Middle Aged; Movement Disorders; Psychiatric Status Rating Scales; Risperidone; Schizophrenia | 2004 |
Oral risperidone with lorazepam versus oral zuclopenthixol with lorazepam in the treatment of acute psychosis in emergency psychiatry: a prospective, comparative, open-label study.
Topics: Adolescent; Adult; Aged; Aggression; Anti-Anxiety Agents; Antipsychotic Agents; Clopenthixol; Drug Therapy, Combination; Emergency Medical Services; Endpoint Determination; Female; Humans; Lorazepam; Male; Middle Aged; Personnel, Hospital; Prospective Studies; Psychiatric Status Rating Scales; Psychomotor Performance; Psychotic Disorders; Risperidone; Social Behavior | 2005 |
Differential early onset of therapeutic response with risperidone vs conventional antipsychotics in patients with chronic schizophrenia.
Topics: Antipsychotic Agents; Chronic Disease; Clopenthixol; Double-Blind Method; Female; Haloperidol; Humans; Male; Perphenazine; Risperidone; Schizophrenia; Treatment Outcome | 2006 |
Long-acting injectable risperidone compared with zuclopenthixol in the treatment of schizophrenia with substance abuse comorbidity.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Clopenthixol; Comorbidity; Delayed-Action Preparations; Double-Blind Method; Female; Follow-Up Studies; Humans; Injections, Intravenous; Male; Middle Aged; Risperidone; Schizophrenia; Substance-Related Disorders | 2006 |
Basal ganglia volumes in drug-naive first-episode schizophrenia patients before and after short-term treatment with either a typical or an atypical antipsychotic drug.
Topics: Adult; Antipsychotic Agents; Basal Ganglia; Caudate Nucleus; Cholinergic Antagonists; Clopenthixol; Drug Administration Schedule; Female; Functional Laterality; Globus Pallidus; Humans; Magnetic Resonance Imaging; Male; Nucleus Accumbens; Putamen; Risperidone; Schizophrenia; Time Factors | 2007 |
Frontal D2/3 Receptor Availability in Schizophrenia Patients Before and After Their First Antipsychotic Treatment: Relation to Cognitive Functions and Psychopathology.
Topics: Adult; Antipsychotic Agents; Attention; Clopenthixol; Cognition; Denmark; Dopamine Antagonists; Female; Frontal Lobe; Humans; Magnetic Resonance Imaging; Male; Molecular Imaging; Receptors, Dopamine D2; Receptors, Dopamine D3; Risperidone; Schizophrenia; Schizophrenic Psychology; Time Factors; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Young Adult | 2016 |
10 other study(ies) available for risperidone and clopenthixol
| Article | Year |
|---|---|
Olanzapine treatment in patients with typical and atypical neuroleptic-associated agranulocytosis.
Topics: Adult; Agranulocytosis; Antipsychotic Agents; Benzodiazepines; Clopenthixol; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Leukocyte Count; Male; Olanzapine; Pirenzepine; Risperidone; Schizophrenia, Paranoid | 1998 |
Treating acquired haemophilia: an ethical conundrum.
Topics: Administration, Oral; Aged; Antipsychotic Agents; Clopenthixol; England; Ethics, Medical; Female; Hemophilia A; Humans; Injections, Intramuscular; Mental Competency; Paranoid Disorders; Risperidone; Treatment Refusal | 2001 |
Local-global processing in early-onset schizophrenia: evidence for an impairment in shifting the spatial scale of attention.
Topics: Adolescent; Affect; Antipsychotic Agents; Attention; Benzodiazepines; Clopenthixol; Diazepam; Female; Flupenthixol; Frontal Lobe; Humans; Male; Olanzapine; Parietal Lobe; Perceptual Disorders; Pirenzepine; Reaction Time; Risperidone; Schizophrenia; Space Perception; Time Factors | 2003 |
[Psychotropic drugs used in a psychiatric hospital (pharmaco-epidemiologic aspects)].
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Carbazoles; Chlorprothixene; Clopenthixol; Data Collection; Dopamine Antagonists; Female; Fluoxetine; Flupenthixol; Hospitals, Psychiatric; Humans; Male; Mental Disorders; Mianserin; Middle Aged; Mirtazapine; Monoamine Oxidase Inhibitors; Moscow; Nootropic Agents; Olanzapine; Pharmacoepidemiology; Phenothiazines; Psychotropic Drugs; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Sulpiride | 2003 |
Chronic antidopaminergic medication might affect amygdala structure in patients with schizophrenia.
Topics: Amygdala; Antipsychotic Agents; Brain; Clopenthixol; Dose-Response Relationship, Drug; Epilepsy, Temporal Lobe; Factor Analysis, Statistical; Flupenthixol; Haloperidol; Hippocampus; Humans; Psychotic Disorders; Risperidone; Schizophrenia; Trifluoperazine | 2004 |
The impact of neuroleptic medication on seizure threshold and duration in electroconvulsive therapy.
Topics: Adult; Aged; Antipsychotic Agents; Benzodiazepines; Brain; Clopenthixol; Clozapine; Dibenzothiazepines; Electric Impedance; Electroconvulsive Therapy; Electroencephalography; Electromyography; Female; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Olanzapine; Quetiapine Fumarate; Risperidone; Seizures; Sulpiride | 2004 |
Metabolic syndrome with different antipsychotics: a multicentre cross-sectional study.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Chi-Square Distribution; Clopenthixol; Clozapine; Cross-Sectional Studies; Female; Humans; Male; Metabolic Syndrome; Middle Aged; Olanzapine; Prevalence; Risk Assessment; Risk Factors; Risperidone; Schizophrenia; Turkey; Young Adult | 2010 |
Stability of medication in early psychosis: a comparison between second-generation and low-dose first-generation antipsychotics.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Benzodiazepines; Chi-Square Distribution; Clopenthixol; Clozapine; Female; Humans; Imidazoles; Indoles; Kaplan-Meier Estimate; Male; Middle Aged; Olanzapine; Perphenazine; Psychotic Disorders; Risperidone; Statistics, Nonparametric; Time Factors; Young Adult | 2009 |
[Combination of two depot antipsychotic drugs].
Topics: Adult; Antipsychotic Agents; Clopenthixol; Delayed-Action Preparations; Drug Therapy, Combination; Female; Humans; Risperidone; Schizophrenia; Treatment Outcome | 2014 |
Letter to the Editor: Rethinking The Cost Of Antipsychotic Treatment: The Average Cost Of The Drugs Used In Turkey In 2020.
Topics: Adenosine Monophosphate; Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Chlorpromazine; Clopenthixol; Clozapine; Flupenthixol; Fluphenazine; Haloperidol; Humans; Olanzapine; Paliperidone Palmitate; Pharmaceutical Preparations; Pimozide; Quetiapine Fumarate; Risperidone; Sulpiride; Trifluoperazine | 2022 |